Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 24;10(3):229-233.
doi: 10.1055/s-0043-1772771. eCollection 2023 Sep.

Review: Advances in the Pathogenesis and Treatment of Immune Thrombocytopenia Associated with Viral Hepatitis

Affiliations
Review

Review: Advances in the Pathogenesis and Treatment of Immune Thrombocytopenia Associated with Viral Hepatitis

Yanmei Xu et al. Glob Med Genet. .

Abstract

Hepatitis B virus and hepatitis C virus are the hepatitis subtypes that most commonly induce immune thrombocytopenia (ITP). Although the pathogenesis of viral hepatitis-associated ITP remains unclear, it may involve antibody cross-reactivity due to molecular mimicry, the formation of virus-platelet immune complexes, and T cell-mediated suppression of bone marrow hematopoiesis. Moreover, there is significant correlation between platelet count and the severity of viral hepatitis, the risk of progression to liver cirrhosis, and clinical prognosis. However, treatment of viral hepatitis-associated ITP is hindered by some antiviral drugs. In this review, we summarize research progress to date on the pathogenesis and treatment of viral hepatitis-related ITP, hoping to provide a reference for clinical diagnosis and treatment.

Keywords: immune thrombocytopenia; pathogenesis; treatment; viral hepatitis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest None declared.

Similar articles

References

    1. Huang C E, Chang J J, Wu Y Y et al.Different impacts of common risk factors associated with thrombocytopenia in patients with hepatitis B virus and hepatitis C virus infection. Biomed J. 2022;45(05):788–797. - PMC - PubMed
    1. Rajan S K, Espina B M, Liebman H A. Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura. Br J Haematol. 2005;129(06):818–824. - PubMed
    1. Liu J, Liang W, Jing W, Liu M. Countdown to 2030: eliminating hepatitis B disease, China. Bull World Health Organ. 2019;97(03):230–238. - PMC - PubMed
    1. Hajarizadeh B, Grebely J, Dore G J. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol. 2013;10(09):553–562. - PubMed
    1. Tejima K, Masuzaki R, Ikeda H et al.Thrombocytopenia is more severe in patients with advanced chronic hepatitis C than B with the same grade of liver stiffness and splenomegaly. J Gastroenterol. 2010;45(08):876–884. - PubMed